13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03585569 (ClinicalTrials.gov) | May 1, 2018 | 16/3/2018 | Treating MS Patients With Lower Extremity Spasticity Using Dysport | A Prospective, Open Label, Single Center Study of Patients With Multiple Sclerosis With Lower Extremity Spasticity Who Are Treated With Dysport | Multiple Sclerosis;Spasticity, Muscle | Biological: Abobotulinumtoxin A | Neurology Center of New England P.C. | Ipsen | Unknown status | N/A | N/A | All | 30 | Phase 3 | United States |